Trials / Terminated
TerminatedNCT02461524
Endurant Evo International Clinical Trial
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 69 (actual)
- Sponsor
- Medtronic Cardiovascular · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this trial is to evaluate the safety and effectiveness of the Endurant Evo Abdominal Aortic Aneurysm (AAA) Stent graft system for endovascular treatment of subjects with infrarenal abdominal aortic or aortoiliac aneurysms.
Detailed description
The Endurant Evo International Clinical Trial is a prospective, multi-center, premarket, non-randomized, single-arm trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Endurant Evo AAA Stent Graft System | |
| PROCEDURE | Endovascular aneurysm repair (EVAR) |
Timeline
- Start date
- 2015-06-01
- Primary completion
- 2021-06-25
- Completion
- 2021-06-25
- First posted
- 2015-06-03
- Last updated
- 2024-04-01
- Results posted
- 2024-04-01
Locations
9 sites across 5 countries: Austria, Belgium, Denmark, Netherlands, Sweden
Source: ClinicalTrials.gov record NCT02461524. Inclusion in this directory is not an endorsement.